Andere Sprachen Novavax, Inc.

Aktien

A2PKMZ

US6700024010

NVAX

Biotechnologie

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 16.01.2026			% 5 Tage	Veränd. 1. Jan.
8,010 ^USD	+2,96 %		+10,18 %	+19,20 %

15.01.	Novavax, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 04:30 PM
09.12.	FDA untersucht möglichen Zusammenhang zwischen Covid-Impfungen und Todesfällen bei Erwachsenen - Bloomberg News	RE

Andere Sprachen

07.01.	Imunon, Inc. Announces Chief Financial Officer Changes, Effective January 14, 2026
07.01.	Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12.12.	Wall Street : Les baisses de taux ne vendent plus du rêve
12.12.	Rate Cuts Can't Buy Confidence
09.12.	Fda probes if Covid shots might be linked to deaths of adults - Bloomberg News
01.12.	Moderna, Other Pharma Stocks Close Lower After US FDA Reportedly Plans to Toughen Vaccine Approval
01.12.	USA: recul en bourse des laboratoires sur fond d'incertitudes sur les vaccins
01.12.	USA-Les valeurs à suivre à Wall Street (actualisé)
13.11.	Cisco : Alphabet, Cisco, Walt Disney...les valeurs à suivre aujourd'hui à Wall Street
13.11.	Novavax : reçoit une lourde charge de l'un de ses actionnaires
13.11.	USA-Les valeurs à suivre à Wall Street (actualisé)
12.11.	Shah Capital pushes for Novavax sale
12.11.	Shah Capital pushes for Novavax sale, warns of proxy fight
12.11.	Shah Capital Urges Novavax Board to Address Operational Inefficiencies and Consider Strategic Merger to Maximize Vaccine Potential
12.11.	Novavax to Participate in Jefferies London Healthcare Conference
06.11.	Novavax delays profitability target with eyes on Sanofi-led launches
06.11.	Novavax, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
06.11.	Novavax Stock Edges Higher After 2025 Adjusted Revenue Forecast Raised
06.11.	Earnings Flash (NVAX) Novavax, Inc. Reports Q3 Revenue $70.4M, vs. FactSet Est of $42.1M
06.11.	Earnings Flash (NVAX) Novavax Posts Q3 Net Loss $1.25 a Share, vs. FactSet Est of $1.20 Loss
06.11.	Novavax : Q3 Reports & Financials (nvax q3 25 earnings presentation)
06.11.	Novavax: Q3 Earnings Snapshot
06.11.	Novavax beats quarterly revenue estimates on milestone payment
06.11.	Novavax defers profitability target by a year on weak COVID vaccine sales
06.11.	Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Filter

Schlagzeilen

Novavax steigt nach 1,2 Milliarden Dollar Sanofi-Impfstoff-Deal

Am 10. Mai 2024 um 19:36 Uhr